323 results
Keyword Lacidipina Teva Remove keyword
-
List item
National expert: Hanna Sekita-Stocka, The Office for Registration of Medicinal Products, Medical Devices and Biocides (updated)
- Declaration of interests - 80.2 KB | PDF
- Curriculum Vitae - 17.08 KB | PDF
Type of Interest Declared Teva Pharmaceuticals Polska Sp … -
List item
National expert: Judit Fehér, Medicines Authority (updated)
- Declaration of interests - 79.83 KB | PDF
- Curriculum Vitae - 22.35 KB | PDF
Quality Assurance Pharmacist TEVA Pharmaceutical Works Private … -
List item
National expert: Joke Jaarsma, European Medicines Agency (updated)
- Declaration of interests - 80.86 KB | PDF
- Curriculum Vitae - 17.29 KB | PDF
in 2021 SANOFI 20,000 TEVA 40,000 EUR funding in 2021 UCB … -
List item
National expert: Edward Laane, European Medicines Agency (updated)
- Declaration of interests - 84.03 KB | PDF
- Curriculum Vitae - 24.2 KB | PDF
comorbities 06/2011-10/2013 Teva TL011 (Biosimilar, anti-CD20) CD20-positive … -
List item
National expert: Jean-Yves Reginster, Federal Agency for Medicines and Health Products (updated)
- Declaration of interests - 81.89 KB | PDF
- Curriculum Vitae - 18.13 KB | PDF
OSTEOPOROSIS 02/2020-08/2020 TEVA OSTEOARTHRITIS 12/2020-03/2021 … -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 2-5 May 2022 (updated)
European Medicines Agency, Amsterdam, the Netherlands, from 02/05/2022 to 05/05/2022, Last updated: 06/02/2023 -
List item
List of medicines under additional monitoring (updated)
Last updated: 25/01/2023substance and new biological Teva GmbH https://www.ema.europa …
-
List item
PRAC: Agendas, minutes and highlights (updated)
Last updated: 06/02/2023 -
List item
Public data from Article 57 database
Last updated: 17/10/2022 -
List item
CHMP: Agendas, minutes and highlights (updated)
Last updated: 27/01/2023 -
List item
PRAC recommendations on safety signals (updated)
Last updated: 06/02/2023 -
List item
Committee for Medicinal Products for Human Use (CHMP): 7-10 November 2022 (updated)
European Medicines Agency, Amsterdam, the Netherlands, from 07/11/2022 to 10/11/2022, Last updated: 10/01/2023 -
List item
Regulatory and scientific virtual conference on RNA-based medicines (updated)
Online, 09:00 - 16:30 Amsterdam time (CET), 02/02/2023, Last updated: 08/02/2023non-executive director of Teva and Adaptimmune, and is … -
List item
Paediatric Committee (PDCO): 13-16 December 2022 (updated)
Virtual meeting, from 13/12/2022 to 16/12/2022, Last updated: 08/02/2023 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 7-10 March 2022
European Medicines Agency, Amsterdam, the Netherlands, from 07/03/2022 to 10/03/2022, Last updated: 22/11/2022 -
List item
Paediatric Committee (PDCO): 17-20 January 2023 (updated)
Virtual meeting, from 17/01/2023 to 20/01/2023, Last updated: 17/01/2023 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 29 November-2 December 2021
European Medicines Agency, Amsterdam, the Netherlands, from 29/11/2021 to 02/12/2021, Last updated: 04/10/2022 -
List item
Committee for Medicinal Products for Human Use (CHMP): 10-13 October 2022
European Medicines Agency, Amsterdam, the Netherlands, from 10/10/2022 to 13/10/2022, Last updated: 23/11/2022 -
List item
Newsletters (updated)
Last updated: 06/02/2023 -
List item
Committee for Medicinal Products for Human Use (CHMP): 20-23 June 2022
European Medicines Agency, Amsterdam, the Netherlands, from 20/06/2022 to 23/06/2022, Last updated: 18/08/2022 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 10-13 January 2022
European Medicines Agency, Amsterdam, the Netherlands, from 10/01/2022 to 13/01/2022, Last updated: 07/10/2022 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 28 November - 1 December 2022
European Medicines Agency, Amsterdam, the Netherlands, from 28/11/2022 to 01/12/2022, Last updated: 29/11/2022 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 25-28 October 2021
European Medicines Agency, Amsterdam, the Netherlands, from 25/10/2021 to 28/10/2021, Last updated: 02/08/2022 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 26-29 September 2022
European Medicines Agency, Amsterdam, the Netherlands, from 26/09/2022 to 29/09/2022, Last updated: 04/07/2022 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 7-10 June 2022
European Medicines Agency, Amsterdam, the Netherlands, from 07/06/2022 to 10/06/2022, Last updated: 07/06/2022